Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print February 5, 2008
DOI: 10.2337/db07-1692

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Figures
Right arrow All Versions of this Article:
db07-1692v1
57/5/1284    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKenzie, M. D.
Right arrow Articles by Thomas, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKenzie, M. D.
Right arrow Articles by Thomas, H. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Pro-apoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic β cells

Mark D. McKenzie, BSc(Hons)1, Emma M. Carrington, BSc(Hons)1, Thomas Kaufmann, PhD2, Andreas Strasser, PhD2, David C.S. Huang, PhD2, Thomas W.H. Kay, PhD, FRACP1, Janette Allison, PhD1, and Helen E. Thomas, PhD1

1 St. Vincent's Institute, 41 Victoria Parade, Fitzroy, 3065, Australia
2 The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3050, Australia

Objective: Apoptosis of pancreatic β cells is critical in both diabetes development and failure of islet transplantation. The role in these processes of pro- and anti-apoptotic Bcl-2 family proteins, that regulate apoptosis by controlling mitochondrial integrity, remains poorly understood. We investigated the role of the BH3-only protein Bid and the multi-BH domain pro-apoptotic Bax, Bak as well as pro-survival Bcl-2 in β-cell apoptosis.

Research Design And Methods: We isolated islets from mice lacking, Bid, Bax or Bak and those over-expressing Bcl-2 and exposed them to Fas ligand, TNF{alpha}, and pro-inflammatory cytokines or cytotoxic stimuli that activate the mitochondrial apoptotic pathway (staurosporine, etoposide, {gamma}-radiation, tunicamycin, and thapsigargin). Nuclear fragmentation was measured by flow cytometry.

Results: Development and function of islets was not affected by loss of Bid, and Bid-deficient islets were as susceptible as wild-type islets to cytotoxic stimuli that cause apoptosis via the mitochondrial pathway. In contrast, Bid-deficient islets and those over-expressing anti-apoptotic Bcl-2 were protected from Fas ligand-induced apoptosis. Bid-deficient islets were also resistant to apoptosis induced by TNF{alpha} plus cycloheximide and were partially resistant to pro-inflammatory cytokine-induced death. Loss of the multi-BH domain pro-apoptotic Bax or Bak protected islets partially from death receptor-induced apoptosis.

Conclusions: These results demonstrate that Bid is essential for death receptor-induced apoptosis of islets, similar to its demonstrated role in hepatocytes. This indicates that blocking Bid activity may be useful for protection of islets from immune-mediated attack and possibly also in other pathological states in which β cells are destroyed.


Correspondence: hthomas{at}svi.edu.au


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.